Patients with human papillomavirus (HPV)-related oropharyngeal cancer generally have favorable outcomes and how well they do depends on the specific details ab…

Head and Neck CancerHead and Neck Squamous Cell CarcinomaOropharynx Cancer+2 more

~Estimated

~$10 – $6,250

University of Maryland, BaltimoreNCT06088381

Phase 2

A Phase II Study of Sacituzumab Govitecan in Combination With Cetuximab in Patients With Recurrent Metastatic HNSCC That Has Progressed After First-Line Therapy

The purpose of this study to find out whether sacituzumab govitecan in combination with cetuximab is an effective and safe treatment approach for people with r…

Squamous Cell Carcinoma of Head and NeckSinus CancerNasal Cavity Cancer+9 more

~Estimated

~$10 – $6,250

Memorial Sloan Kettering Cancer CenterNCT07063212

← PreviousPage 2 of 2Next →